Curaleaf Holdings (CURLF) Gross Margin Growth (3y) (2022 - 2026)

Curaleaf Holdings (CURLF) Gross Margin Growth (3y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 631.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 106.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -673.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -675.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -838.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 33.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -344.00
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn 28.00

Historic Data

Download Data
DateValue
Mar 31, 2026 28.00
Dec 31, 2025 2,835.00
Sep 30, 2025 -177.00
Jun 30, 2025 -645.00
Mar 31, 2025 -668.00
Dec 31, 2024 163.00
Sep 30, 2024 -917.00
Jun 30, 2024 -1,223.00
Dec 31, 2023 -948.00
Sep 30, 2023 -1,918.00
Jun 30, 2023 -3,753.00
Mar 31, 2023 -4,007.00
Dec 31, 2022 -5,630.00
Sep 30, 2022 -4,414.00